Project acronym BIOSUSAMIN
Project The design and development of efficient biocatalytic cascades and biosynthetic pathways for the sustainable production of amines
Researcher (PI) Francesco Mutti
Host Institution (HI) UNIVERSITEIT VAN AMSTERDAM
Call Details Starting Grant (StG), LS9, ERC-2014-STG
Summary The objective of this project is to design and develop biocatalytic cascades, using purified enzymes in vitro, as well as biosynthetic pathways in whole cell microbial organisms. These biocatalytic cascades and biosynthetic pathways will be developed for the synthesis of chiral and achiral amines that are of particular interest for the chemical industry. The amine functionality will be introduced using amine dehydrogenases (AmDHs) as biocatalysts in the pivotal core enzymatic step. AmDHs are a new class of enzymes that have recently been obtained by protein engineering of wild-type amino acid dehydrogenases. However, only two AmDHs have been generated so far and, moreover, they show a limited substrate scope. Therefore protein engineering will be undertaken in order to expand the substrate scope of the already existing AmDHs. In addition, novel AmDHs will be generated starting from different wild-type amino acid dehydrogenases as scaffolds, whose amino acid and DNA sequences are available in databases, literature, libraries, etc. In particular, protein engineering will be focused on the specific chemical targets that are the objectives of the designed biocatalytic cascades and in addition, screening for more diverse substrates will also be carried out. Finally, the AmDHs will be used in combination with other enzymes such as alcohol dehydrogenases, oxidases, alkane monooxygenases, etc., to deliver variously functionalised amines and derivatives as final products with elevated yields, perfect chemo- regio- and stereoselectivity, enhanced atom efficiency and minimum environmental impact. Such an approach will be realised through the design of new pathways that will convert inexpensive starting materials from renewable resources, encompassing the internal recycling of redox equivalents, the use of inorganic ammonia as nitrogen source and, if necessary, only molecular oxygen as the innocuous additional oxidant. Water will be the sole by-product.
Summary
The objective of this project is to design and develop biocatalytic cascades, using purified enzymes in vitro, as well as biosynthetic pathways in whole cell microbial organisms. These biocatalytic cascades and biosynthetic pathways will be developed for the synthesis of chiral and achiral amines that are of particular interest for the chemical industry. The amine functionality will be introduced using amine dehydrogenases (AmDHs) as biocatalysts in the pivotal core enzymatic step. AmDHs are a new class of enzymes that have recently been obtained by protein engineering of wild-type amino acid dehydrogenases. However, only two AmDHs have been generated so far and, moreover, they show a limited substrate scope. Therefore protein engineering will be undertaken in order to expand the substrate scope of the already existing AmDHs. In addition, novel AmDHs will be generated starting from different wild-type amino acid dehydrogenases as scaffolds, whose amino acid and DNA sequences are available in databases, literature, libraries, etc. In particular, protein engineering will be focused on the specific chemical targets that are the objectives of the designed biocatalytic cascades and in addition, screening for more diverse substrates will also be carried out. Finally, the AmDHs will be used in combination with other enzymes such as alcohol dehydrogenases, oxidases, alkane monooxygenases, etc., to deliver variously functionalised amines and derivatives as final products with elevated yields, perfect chemo- regio- and stereoselectivity, enhanced atom efficiency and minimum environmental impact. Such an approach will be realised through the design of new pathways that will convert inexpensive starting materials from renewable resources, encompassing the internal recycling of redox equivalents, the use of inorganic ammonia as nitrogen source and, if necessary, only molecular oxygen as the innocuous additional oxidant. Water will be the sole by-product.
Max ERC Funding
1 497 270 €
Duration
Start date: 2015-05-01, End date: 2020-04-30
Project acronym BIZEB
Project Bio-Imaging of Zoonotic and Emerging Bunyaviruses
Researcher (PI) Juha Huiskonen
Host Institution (HI) HELSINGIN YLIOPISTO
Call Details Consolidator Grant (CoG), LS1, ERC-2014-CoG
Summary We aim to understand host cell entry of enveloped viruses at molecular level. A crucial step in this process is when the viral membrane fuses with the cell membrane. Similarly to cell–cell fusion, this step is mediated by fusion proteins (classes I–III). Several medically important viruses, notably dengue and many bunyaviruses, harbour a class II fusion protein. Class II fusion protein structures have been solved in pre- and post-fusion conformation and in some cases different factors promoting fusion have been determined. However, questions about the most important steps of this key process remain unanswered. I will focus on the entry mechanism of bunyaviruses by using cutting-edge, high spatial and temporal resolution bio-imaging techniques. These viruses have been chosen as a model system to maximise the significance of the project: they form an emerging viral threat to humans and animals, no approved vaccines or antivirals exist for human use and they are less studied than other class II fusion protein systems. Cryo-electron microscopy and tomography will be used to solve high-resolution structures (up to ~3 Å) of viruses, in addition to virus–receptor and virus–membrane complexes. Advanced fluorescence microscopy techniques will be used to probe the dynamics of virus entry and fusion in vivo and in vitro. Deciphering key steps in virus entry is expected to contribute to rational vaccine and drug design. During this project I aim to establish a world-class laboratory in structural and cellular biology of emerging viruses. The project greatly benefits from our unique biosafety level 3 laboratory offering advanced bio-imaging techniques. Furthermore it will also pave way for similar projects on other infectious viruses. Finally the novel computational image processing methods developed in this project will be broadly applicable for the analysis of flexible biological structures, which often pose the most challenging yet interesting questions in structural biology.
Summary
We aim to understand host cell entry of enveloped viruses at molecular level. A crucial step in this process is when the viral membrane fuses with the cell membrane. Similarly to cell–cell fusion, this step is mediated by fusion proteins (classes I–III). Several medically important viruses, notably dengue and many bunyaviruses, harbour a class II fusion protein. Class II fusion protein structures have been solved in pre- and post-fusion conformation and in some cases different factors promoting fusion have been determined. However, questions about the most important steps of this key process remain unanswered. I will focus on the entry mechanism of bunyaviruses by using cutting-edge, high spatial and temporal resolution bio-imaging techniques. These viruses have been chosen as a model system to maximise the significance of the project: they form an emerging viral threat to humans and animals, no approved vaccines or antivirals exist for human use and they are less studied than other class II fusion protein systems. Cryo-electron microscopy and tomography will be used to solve high-resolution structures (up to ~3 Å) of viruses, in addition to virus–receptor and virus–membrane complexes. Advanced fluorescence microscopy techniques will be used to probe the dynamics of virus entry and fusion in vivo and in vitro. Deciphering key steps in virus entry is expected to contribute to rational vaccine and drug design. During this project I aim to establish a world-class laboratory in structural and cellular biology of emerging viruses. The project greatly benefits from our unique biosafety level 3 laboratory offering advanced bio-imaging techniques. Furthermore it will also pave way for similar projects on other infectious viruses. Finally the novel computational image processing methods developed in this project will be broadly applicable for the analysis of flexible biological structures, which often pose the most challenging yet interesting questions in structural biology.
Max ERC Funding
1 998 375 €
Duration
Start date: 2015-04-01, End date: 2020-03-31
Project acronym BrainFrame
Project Automated framework for rapid simulations of high-detail brain models
Researcher (PI) Christiaan Innocentius de Zeeuw
Host Institution (HI) ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Call Details Proof of Concept (PoC), PC1, ERC-2014-PoC
Summary Traditional methods of software modeling and simulation take prohibitive amounts of time to run for the size and complexity of biologically realistic neuron populations (e.g. >1 million). For instance, simulation of a 100 high-detail (Inferior-Olive) neuron-network for 10 minutes of brain time take 42 hours to complete on an modern PC workstation. To tackle this problem - common to the international neuroscience community -, we have turned to hardware-accelerated simulation platforms. We have employed award-winning, FPGA -based, dataflow machines provided by Maxeler Technologies, which offer high-performance computing capabilities and come with programming tools of unprecedented user friendliness. Our current Maxeler setups have offered impressive acceleration rates of more than 4 orders of magnitude (x10000). Despite the achieved speeds, however, we have found the Maxeler programming tools to be cumbersome to learn by neuromodelers with little hardware knowledge. Engineering personnel has, thus, been employed to assist them in (efficiently) translating and deploying their models. To streamline this process and bring a powerful tool directly to the hands of modelers, we propose BrainFrame, a novel system consisting of Maxeler hardware and a comprehensive software toolflow, effectively adding an abstraction level for neuromodelers to work on without specific knowledge of the underlying simulation platform. BrainFrame comprises a “one-stop shop”, integrated solution primarily targeting labs and companies active in the field of brain-modeling research and applications.
Summary
Traditional methods of software modeling and simulation take prohibitive amounts of time to run for the size and complexity of biologically realistic neuron populations (e.g. >1 million). For instance, simulation of a 100 high-detail (Inferior-Olive) neuron-network for 10 minutes of brain time take 42 hours to complete on an modern PC workstation. To tackle this problem - common to the international neuroscience community -, we have turned to hardware-accelerated simulation platforms. We have employed award-winning, FPGA -based, dataflow machines provided by Maxeler Technologies, which offer high-performance computing capabilities and come with programming tools of unprecedented user friendliness. Our current Maxeler setups have offered impressive acceleration rates of more than 4 orders of magnitude (x10000). Despite the achieved speeds, however, we have found the Maxeler programming tools to be cumbersome to learn by neuromodelers with little hardware knowledge. Engineering personnel has, thus, been employed to assist them in (efficiently) translating and deploying their models. To streamline this process and bring a powerful tool directly to the hands of modelers, we propose BrainFrame, a novel system consisting of Maxeler hardware and a comprehensive software toolflow, effectively adding an abstraction level for neuromodelers to work on without specific knowledge of the underlying simulation platform. BrainFrame comprises a “one-stop shop”, integrated solution primarily targeting labs and companies active in the field of brain-modeling research and applications.
Max ERC Funding
149 937 €
Duration
Start date: 2015-02-01, End date: 2016-01-31
Project acronym CAFES
Project Causal Analysis of Feedback Systems
Researcher (PI) Joris Marten Mooij
Host Institution (HI) UNIVERSITEIT VAN AMSTERDAM
Call Details Starting Grant (StG), PE6, ERC-2014-STG
Summary Many questions in science, policy making and everyday life are of a causal nature: how would changing A influence B? Causal inference, a branch of statistics and machine learning, studies how cause-effect relationships can be discovered from data and how these can be used for making predictions in situations where a system has been perturbed by an external intervention. The ability to reliably make such causal predictions is of great value for practical applications in a variety of disciplines. Over the last two decades, remarkable progress has been made in the field. However, even though state-of-the-art causal inference algorithms work well on simulated data when all their assumptions are met, there is still a considerable gap between theory and practice. The goal of CAFES is to bridge that gap by developing theory and algorithms that will enable large-scale applications of causal inference in various challenging domains in science, industry and decision making.
The key challenge that will be addressed is how to deal with cyclic causal relationships ("feedback loops"). Feedback loops are very common in many domains (e.g., biology, economy and climatology), but have mostly been ignored so far in the field. Building on recently established connections between dynamical systems and causal models, CAFES will develop theory and algorithms for causal modeling, reasoning, discovery and prediction for cyclic causal systems. Extensions to stationary and non-stationary processes will be developed to advance the state-of-the-art in causal analysis of time-series data. In order to optimally use available resources, computationally efficient and statistically robust algorithms for causal inference from observational and interventional data in the context of confounders and feedback will be developed. The work will be done with a strong focus on applications in molecular biology, one of the most promising areas for automated causal inference from data.
Summary
Many questions in science, policy making and everyday life are of a causal nature: how would changing A influence B? Causal inference, a branch of statistics and machine learning, studies how cause-effect relationships can be discovered from data and how these can be used for making predictions in situations where a system has been perturbed by an external intervention. The ability to reliably make such causal predictions is of great value for practical applications in a variety of disciplines. Over the last two decades, remarkable progress has been made in the field. However, even though state-of-the-art causal inference algorithms work well on simulated data when all their assumptions are met, there is still a considerable gap between theory and practice. The goal of CAFES is to bridge that gap by developing theory and algorithms that will enable large-scale applications of causal inference in various challenging domains in science, industry and decision making.
The key challenge that will be addressed is how to deal with cyclic causal relationships ("feedback loops"). Feedback loops are very common in many domains (e.g., biology, economy and climatology), but have mostly been ignored so far in the field. Building on recently established connections between dynamical systems and causal models, CAFES will develop theory and algorithms for causal modeling, reasoning, discovery and prediction for cyclic causal systems. Extensions to stationary and non-stationary processes will be developed to advance the state-of-the-art in causal analysis of time-series data. In order to optimally use available resources, computationally efficient and statistically robust algorithms for causal inference from observational and interventional data in the context of confounders and feedback will be developed. The work will be done with a strong focus on applications in molecular biology, one of the most promising areas for automated causal inference from data.
Max ERC Funding
1 405 652 €
Duration
Start date: 2015-09-01, End date: 2020-08-31
Project acronym Cancer-Recurrence
Project Tumor cell death supports recurrence of cancer
Researcher (PI) Jacobus Emiel van Rheenen
Host Institution (HI) STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
Call Details Consolidator Grant (CoG), LS4, ERC-2014-CoG
Summary Introduction: Current anti-cancer treatments are often inefficient, while many patients initially benefit from anti-cancer drugs eventually experience relapse of resistant tumors throughout the body. Current clinical strategies mainly aim at inducing tumor cell death, but this induction may have unintentional and unwanted side effects on surviving tumor cells.
Preliminary data: We show that after chemotherapy-induced initial regression, PyMT mammary tumors reappear. During regression, we observe an increased number of cells that have undergone epithelial-mesenchymal transition (EMT) and become migratory. We show that migration can be induced upon uptake of extracellular vesicles (e.g. apoptotic bodies). Our findings suggest that EMT is induced upon chemotherapy, through e.g. EV uptake, potentially leading to migration and growth of surviving cells.
Hypothesis and main aim: Based on preliminary data, we hypothesize that tumor cell death induces migration and growth of the surviving tumor cells. We aim to identify the key cell types and mechanisms that mediate this effect, and establish whether interference with these cells and mechanisms can reduce recurrence of tumors after chemotherapy.
Approach: We have developed unique intravital imaging tools and genetically engineered fluorescent mice to visualize and characterize if and how dying tumor cells can affect surrounding surviving tumor and stromal cells. We will test whether dying tumor cells can influence the growth, migration, dissemination and metastasis of surviving tumor cells directly or indirectly through stromal cells. We will identify potential targets to block the influence of the dying tumor cells, and test whether this blockade inhibits the unintended side-effects of tumor cell death.
Conclusion: With the studies proposed in this grant, we will gain fundamental insights on how induction of tumor cell death, the universal aim of therapy, could play a role in growth and spread of surviving tumor cells.
Summary
Introduction: Current anti-cancer treatments are often inefficient, while many patients initially benefit from anti-cancer drugs eventually experience relapse of resistant tumors throughout the body. Current clinical strategies mainly aim at inducing tumor cell death, but this induction may have unintentional and unwanted side effects on surviving tumor cells.
Preliminary data: We show that after chemotherapy-induced initial regression, PyMT mammary tumors reappear. During regression, we observe an increased number of cells that have undergone epithelial-mesenchymal transition (EMT) and become migratory. We show that migration can be induced upon uptake of extracellular vesicles (e.g. apoptotic bodies). Our findings suggest that EMT is induced upon chemotherapy, through e.g. EV uptake, potentially leading to migration and growth of surviving cells.
Hypothesis and main aim: Based on preliminary data, we hypothesize that tumor cell death induces migration and growth of the surviving tumor cells. We aim to identify the key cell types and mechanisms that mediate this effect, and establish whether interference with these cells and mechanisms can reduce recurrence of tumors after chemotherapy.
Approach: We have developed unique intravital imaging tools and genetically engineered fluorescent mice to visualize and characterize if and how dying tumor cells can affect surrounding surviving tumor and stromal cells. We will test whether dying tumor cells can influence the growth, migration, dissemination and metastasis of surviving tumor cells directly or indirectly through stromal cells. We will identify potential targets to block the influence of the dying tumor cells, and test whether this blockade inhibits the unintended side-effects of tumor cell death.
Conclusion: With the studies proposed in this grant, we will gain fundamental insights on how induction of tumor cell death, the universal aim of therapy, could play a role in growth and spread of surviving tumor cells.
Max ERC Funding
2 000 000 €
Duration
Start date: 2015-09-01, End date: 2020-08-31
Project acronym CapTherPV
Project Integration of Capacitor, Thermoelectric and PhotoVoltaic thin films for efficient energy conversion and storage
Researcher (PI) Isabel Maria Das Merces Ferreira
Host Institution (HI) NOVA ID FCT - ASSOCIACAO PARA A INOVACAO E DESENVOLVIMENTO DA FCT
Call Details Consolidator Grant (CoG), PE8, ERC-2014-CoG
Summary The possibility of having a unique device that converts thermal and photonics energy into electrical energy and simultaneously stores it, is something dreamed by the PI since the beginning of her research career. To achieve that goal, this project aims to gather, in a single substrate, solar cells with up-conversion nanoparticles, thermoelectrics and graphene super-capacitor, all made of thin films. These three main components will be developed separately and integrated sequentially. The innovation proposed is not limited to the integration of components, but rely in ground-breaking concepts: 1) thermoelectric elements based on thin film (TE-TF) oxides; 2) plasmonic nanoparticles for up conversion of near infrared radiation to visible emission in solar cells; 3) graphene super-capacitors; 4) integration and optimization of all components in a single CapTherPV device. This ambitious project will bring new insights at large area, low cost and flexible energy harvesting and comes from an old idea of combining energy conversion and storage that has been pursued by the PI. She started her career in amorphous silicon thin film solar cells, later she started the development of thin film batteries and more recently started a research line in thermoelectric films. If approved, this project will give financial support to consolidate the research being carried out and will give independence to the PI in terms of resources and creative think. More importantly, will facilitate the concretization of the dream that has been pursued with hard work.
Summary
The possibility of having a unique device that converts thermal and photonics energy into electrical energy and simultaneously stores it, is something dreamed by the PI since the beginning of her research career. To achieve that goal, this project aims to gather, in a single substrate, solar cells with up-conversion nanoparticles, thermoelectrics and graphene super-capacitor, all made of thin films. These three main components will be developed separately and integrated sequentially. The innovation proposed is not limited to the integration of components, but rely in ground-breaking concepts: 1) thermoelectric elements based on thin film (TE-TF) oxides; 2) plasmonic nanoparticles for up conversion of near infrared radiation to visible emission in solar cells; 3) graphene super-capacitors; 4) integration and optimization of all components in a single CapTherPV device. This ambitious project will bring new insights at large area, low cost and flexible energy harvesting and comes from an old idea of combining energy conversion and storage that has been pursued by the PI. She started her career in amorphous silicon thin film solar cells, later she started the development of thin film batteries and more recently started a research line in thermoelectric films. If approved, this project will give financial support to consolidate the research being carried out and will give independence to the PI in terms of resources and creative think. More importantly, will facilitate the concretization of the dream that has been pursued with hard work.
Max ERC Funding
1 999 375 €
Duration
Start date: 2015-07-01, End date: 2020-06-30
Project acronym CELL HYBRIDGE
Project 3D Scaffolds as a Stem Cell Delivery System for Musculoskeletal Regenerative Medicine
Researcher (PI) Lorenzo Moroni
Host Institution (HI) UNIVERSITEIT MAASTRICHT
Call Details Starting Grant (StG), PE8, ERC-2014-STG
Summary Aging worldwide population demands new solutions to permanently restore damaged tissues, thus reducing healthcare costs. Regenerative medicine offers alternative therapies for tissue repair. Although first clinical trials revealed excellent initial response after implantation of these engineered tissues, long-term follow-ups demonstrated that degeneration and lack of integration with the surrounding tissues occur. Causes are related to insufficient cell-material interactions and loss of cell potency when cultured in two-dimensional substrates, among others.
Stem cells are a promising alternative due to their differentiation potential into multiple lineages. Yet, better control over cell-material interactions is necessary to maintain tissue engineered constructs in time. It is crucial to control stem cell quiescence, proliferation and differentiation in three-dimensional scaffolds while maintaining cells viable in situ. Stem cell activity is controlled by a complex cascade of signals called “niche”, where the extra-cellular matrix (ECM) surrounding the cells play a major role. Designing scaffolds inspired by this cellular niche and its ECM may lead to engineered tissues with instructive properties characterized by enhanced homeostasis, stability and integration with the surrounding milieu.
This research proposal aims at engineering constructs where scaffolds work as stem cell delivery systems actively controlling cell quiescence, proliferation, and differentiation. This challenge will be approached through a biomimetic design inspired by the mesenchymal stem cell niche. Three different scaffolds will be combined to achieve this purpose: (i) a scaffold designed to maintain cell quiescence; (ii) a scaffold designed to promote cell proliferation; and (iii) a scaffold designed to control cell differentiation. To prove the design criteria the evaluation of stem cell quiescence, proliferation, and differentiation will be assessed for musculoskeletal regenerative therapies.
Summary
Aging worldwide population demands new solutions to permanently restore damaged tissues, thus reducing healthcare costs. Regenerative medicine offers alternative therapies for tissue repair. Although first clinical trials revealed excellent initial response after implantation of these engineered tissues, long-term follow-ups demonstrated that degeneration and lack of integration with the surrounding tissues occur. Causes are related to insufficient cell-material interactions and loss of cell potency when cultured in two-dimensional substrates, among others.
Stem cells are a promising alternative due to their differentiation potential into multiple lineages. Yet, better control over cell-material interactions is necessary to maintain tissue engineered constructs in time. It is crucial to control stem cell quiescence, proliferation and differentiation in three-dimensional scaffolds while maintaining cells viable in situ. Stem cell activity is controlled by a complex cascade of signals called “niche”, where the extra-cellular matrix (ECM) surrounding the cells play a major role. Designing scaffolds inspired by this cellular niche and its ECM may lead to engineered tissues with instructive properties characterized by enhanced homeostasis, stability and integration with the surrounding milieu.
This research proposal aims at engineering constructs where scaffolds work as stem cell delivery systems actively controlling cell quiescence, proliferation, and differentiation. This challenge will be approached through a biomimetic design inspired by the mesenchymal stem cell niche. Three different scaffolds will be combined to achieve this purpose: (i) a scaffold designed to maintain cell quiescence; (ii) a scaffold designed to promote cell proliferation; and (iii) a scaffold designed to control cell differentiation. To prove the design criteria the evaluation of stem cell quiescence, proliferation, and differentiation will be assessed for musculoskeletal regenerative therapies.
Max ERC Funding
1 500 000 €
Duration
Start date: 2015-05-01, End date: 2020-04-30
Project acronym CHEMCOMRHIZO
Project Chemical communication in the rhizosphere of plants
Researcher (PI) Jan Hendrik Bouwmeester
Host Institution (HI) UNIVERSITEIT VAN AMSTERDAM
Call Details Advanced Grant (AdG), LS9, ERC-2014-ADG
Summary Plants secrete metabolites to communicate with other organisms in their rhizosphere. An exciting example of rhizosphere signalling molecules are the strigolactones. These are used by the friends of plants, the arbuscular mycorrhizal fungi, for host detection but also by their enemies, root parasitic plants. Furthermore, they have an endogenous signalling function, as a plant hormone that regulates shoot branching and root architecture. I postulate that this dual positive and negative signalling role of the strigolactones is the result of a paradigm: enemies of plants recruit molecules that are essential to the plant as cues. This paradigm has two important implications: 1) other plant-produced signalling molecules known to be abused by plant enemies likely have another, beneficial essential function in plants and 2) the involvement of multiple, positive and negative, biological functions exerts a selective pressure on these signalling molecules that results in the evolution of diversity in structure and biological specificity. In the project proposed here I will address implication 1) using an innovative approach in a new area by setting out to discover a new signalling role for plant parasitic cyst nematode hatching stimulants and I will investigate implication 2) by studying how biological specificity in strigolactones and hatching stimulants is mediated by the creation of structural diversity and the concomitant changes in perception, in parasitic plants and nematodes. This work will shed light on the significance of structural diversity in signalling molecules and the co-evolution of perception and may result in the discovery of a new class of signalling molecules in plants. It will also provide the fundamental knowledge enabling biotechnological and agronomical applications to optimise colonisation by AM fungi and plant development, and control parasitation by root parasitic plants and cyst nematodes.
Summary
Plants secrete metabolites to communicate with other organisms in their rhizosphere. An exciting example of rhizosphere signalling molecules are the strigolactones. These are used by the friends of plants, the arbuscular mycorrhizal fungi, for host detection but also by their enemies, root parasitic plants. Furthermore, they have an endogenous signalling function, as a plant hormone that regulates shoot branching and root architecture. I postulate that this dual positive and negative signalling role of the strigolactones is the result of a paradigm: enemies of plants recruit molecules that are essential to the plant as cues. This paradigm has two important implications: 1) other plant-produced signalling molecules known to be abused by plant enemies likely have another, beneficial essential function in plants and 2) the involvement of multiple, positive and negative, biological functions exerts a selective pressure on these signalling molecules that results in the evolution of diversity in structure and biological specificity. In the project proposed here I will address implication 1) using an innovative approach in a new area by setting out to discover a new signalling role for plant parasitic cyst nematode hatching stimulants and I will investigate implication 2) by studying how biological specificity in strigolactones and hatching stimulants is mediated by the creation of structural diversity and the concomitant changes in perception, in parasitic plants and nematodes. This work will shed light on the significance of structural diversity in signalling molecules and the co-evolution of perception and may result in the discovery of a new class of signalling molecules in plants. It will also provide the fundamental knowledge enabling biotechnological and agronomical applications to optimise colonisation by AM fungi and plant development, and control parasitation by root parasitic plants and cyst nematodes.
Max ERC Funding
2 498 674 €
Duration
Start date: 2015-12-01, End date: 2020-11-30
Project acronym ChildCogn
Project Novel solutions for assessing child cognitive function
Researcher (PI) Jukka Mattias Leppänen
Host Institution (HI) TAMPEREEN KORKEAKOULUSAATIO SR
Call Details Proof of Concept (PoC), PC1, ERC-2014-PoC
Summary An important responsibility of primary health care in most societies is to conduct regular check-ups of children’s physical, cognitive, and social development, and to identify problems at an early stage to arrange for appropriate support and special care. Whereas well-validated methods exist for monitoring physical growth (e.g., WHO growth standards), there is a lack of standardized methods for monitoring other key aspects of early development (e.g., cognitive development). The present project examines the possibilities to develop novel solutions for assessing children's cognitive function. The project activities are aimed at developing the concept of new types of cognitive assessment techniques, testing of a prototype, and surveying end-user experiences and potential markets for the prototype.
Summary
An important responsibility of primary health care in most societies is to conduct regular check-ups of children’s physical, cognitive, and social development, and to identify problems at an early stage to arrange for appropriate support and special care. Whereas well-validated methods exist for monitoring physical growth (e.g., WHO growth standards), there is a lack of standardized methods for monitoring other key aspects of early development (e.g., cognitive development). The present project examines the possibilities to develop novel solutions for assessing children's cognitive function. The project activities are aimed at developing the concept of new types of cognitive assessment techniques, testing of a prototype, and surveying end-user experiences and potential markets for the prototype.
Max ERC Funding
148 709 €
Duration
Start date: 2015-02-01, End date: 2016-07-31
Project acronym CHIRALSENSE
Project CHIRALSENSE : Sensing Chirality using cavity-enhanced polarimetry: advances in sensitivity and time-resolution
Researcher (PI) Theodoros Petros Rakitzis
Host Institution (HI) IDRYMA TECHNOLOGIAS KAI EREVNAS
Call Details Proof of Concept (PoC), PC1, ERC-2014-PoC
Summary Chiral sensing is crucial to many fields, constituting a multibillion Euro industry. The polarimetric techniques of optical rotation (OR) and circular dichroism (CD) are the most widely-used techniques for the analysis of chiral samples, ranging from the measurement of protein structure, to quality control in the pharmaceutical, chemical, cosmetic, and food industries. In general, the OR and CD signals are very small, which place severe constraints on detection sensitivity and time-resolution. Through the ERC grant TRICEPS, we have developed a groundbreaking cavity-based polarimeter [Sofikitis et al. Nature 514, 76 (2014)] with 3 main advantages: (a) The OR and CD signals are enhanced by the number of cavity passes (typically 1000); (b) birefringent backgrounds are suppressed; (c) signal reversals give absolute polarimetry measurements, not requiring the sample to be removed to measure a null sample. These advantages represent orders-of-magnitude improvements in sensitivity, acquisition time, and sample size, with respect to commercially available polarimeters, and will reduce measurement time, sample sizes, and costs in the chiral sensing industry. We propose, through CHIRALSENSE, to: (1) file a non-provisional US patent application, to follow our filing of a US provisional patent application for our polarimeter, which will provide IPR protection for the first stages of the product development; (2) demonstrate our existing CHIRALSENSE polarimeter to leading polarimetry companies, by performing measurements on commercial-standard samples; and (3) adapt our polarimeter to measure complex samples separated using HPLC (high-performance liquid chromatography) for analytical chemistry applications, to be demonstrated to leading HPLC companies.
Summary
Chiral sensing is crucial to many fields, constituting a multibillion Euro industry. The polarimetric techniques of optical rotation (OR) and circular dichroism (CD) are the most widely-used techniques for the analysis of chiral samples, ranging from the measurement of protein structure, to quality control in the pharmaceutical, chemical, cosmetic, and food industries. In general, the OR and CD signals are very small, which place severe constraints on detection sensitivity and time-resolution. Through the ERC grant TRICEPS, we have developed a groundbreaking cavity-based polarimeter [Sofikitis et al. Nature 514, 76 (2014)] with 3 main advantages: (a) The OR and CD signals are enhanced by the number of cavity passes (typically 1000); (b) birefringent backgrounds are suppressed; (c) signal reversals give absolute polarimetry measurements, not requiring the sample to be removed to measure a null sample. These advantages represent orders-of-magnitude improvements in sensitivity, acquisition time, and sample size, with respect to commercially available polarimeters, and will reduce measurement time, sample sizes, and costs in the chiral sensing industry. We propose, through CHIRALSENSE, to: (1) file a non-provisional US patent application, to follow our filing of a US provisional patent application for our polarimeter, which will provide IPR protection for the first stages of the product development; (2) demonstrate our existing CHIRALSENSE polarimeter to leading polarimetry companies, by performing measurements on commercial-standard samples; and (3) adapt our polarimeter to measure complex samples separated using HPLC (high-performance liquid chromatography) for analytical chemistry applications, to be demonstrated to leading HPLC companies.
Max ERC Funding
150 000 €
Duration
Start date: 2015-04-01, End date: 2016-09-30